These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 24980912)

  • 21. Effect of formulation variables on the percutaneous permeation of ketoprofen from gel formulations.
    El-Kattan AF; Asbill CS; Kim N; Michniak BB
    Drug Deliv; 2000; 7(3):147-53. PubMed ID: 10989915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers.
    Hashmat D; Shoaib MH; Ali FR; Siddiqui F
    PLoS One; 2020; 15(2):e0228908. PubMed ID: 32107483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
    Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
    Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Film drying and complexation effects in the simultaneous skin permeation of ketoprofen and propylene glycol from simple gel formulations.
    Bowen JL; Heard CM
    Int J Pharm; 2006 Jan; 307(2):251-7. PubMed ID: 16289881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of creams and ointments as suitable formulations for peldesine.
    Viegas TX; Van Winkle LL; Lehman PA; Franz SF; Franz TJ
    Int J Pharm; 2001 May; 219(1-2):73-80. PubMed ID: 11337167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a new topical gel-spray formulation of ketoprofen lysine salt in the rat: percutaneous permeation in vitro and in vivo and pharmacological activity.
    Porzio S; Caselli G; Pellegrini L; Pallottini V; Del Rosario M; Coppola A; Boltri L; Gentile M; Clavenna G; Melillo G
    Pharmacol Res; 1998 Jan; 37(1):41-7. PubMed ID: 9503479
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of propylene glycol on ibuprofen absorption into human skin in vivo.
    Herkenne C; Naik A; Kalia YN; Hadgraft J; Guy RH
    J Pharm Sci; 2008 Jan; 97(1):185-97. PubMed ID: 17497726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal absorption of propofol in rats.
    Takahashi Y; Yamato K; Akiyama H; Tsuji K; Onishi H; Machida Y
    Biol Pharm Bull; 2005 May; 28(5):870-5. PubMed ID: 15863896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles.
    Aungst BJ; Blake JA; Rogers NJ; Hussain MA
    J Pharm Sci; 1990 Dec; 79(12):1072-6. PubMed ID: 2079653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vehicles and enhancers on transdermal delivery of clebopride.
    Rhee YS; Huh JY; Park CW; Nam TY; Yoon KR; Chi SC; Park ES
    Arch Pharm Res; 2007 Sep; 30(9):1155-61. PubMed ID: 17958335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transdermal delivery of theophylline using an ethanol/panasate 800-ethylcellulose gel preparation.
    Lee CK; Kitagawa K; Uchida T; Kim NS; Goto S
    Biol Pharm Bull; 1995 Jan; 18(1):176-80. PubMed ID: 7735237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the transdermal absorption of nimesulide from three commercially available gel formulations.
    Dayal P; Kanikkannan N; Singh A; Sing M
    Drug Dev Ind Pharm; 2002 Mar; 28(3):297-304. PubMed ID: 12026222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Percutaneous absorption of physiologically active peptides, ebiratide and elcatonin, in rats.
    Ogiso T; Paku T; Iwaki M; Tanino T; Nishioka S
    Biol Pharm Bull; 1994 Aug; 17(8):1094-100. PubMed ID: 7820115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of penetration enhancers on the in-vitro percutaneous absorption of progesterone.
    Valenta C; Wedenig S
    J Pharm Pharmacol; 1997 Oct; 49(10):955-9. PubMed ID: 9364402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride.
    Namdeo A; Jain N
    J Control Release; 2002 Aug; 82(2-3):223-36. PubMed ID: 12175739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation optimization of meloxicam sodium gel using response surface methodology.
    Chang JS; Huang YB; Hou SS; Wang RJ; Wu PC; Tsai YH
    Int J Pharm; 2007 Jun; 338(1-2):48-54. PubMed ID: 17360134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of vehicle and region of application on absorption of hydrocortisone through canine skin.
    Mills PC; Magnusson BM; Cross SE
    Am J Vet Res; 2005 Jan; 66(1):43-7. PubMed ID: 15691034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin.
    Panchagnula R; Salve PS; Thomas NS; Jain AK; Ramarao P
    Int J Pharm; 2001 May; 219(1-2):95-105. PubMed ID: 11337170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of tretinoin gels for enhanced transdermal delivery.
    Shin SC; Kim HJ; Oh IJ; Cho CW; Yang KH
    Eur J Pharm Biopharm; 2005 May; 60(1):67-71. PubMed ID: 15848058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the transdermal delivery of estradiol from two gel formulations.
    Walters KA; Brain KR; Green DM; James VJ; Watkinson AC; Sands RH
    Maturitas; 1998 Jun; 29(2):189-95. PubMed ID: 9651909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.